Emerging reports of SARS-CoV-2 breakthrough infections entail methodical genomic surveillance for determining the efficacy of vaccines. This study elaborates genomic analysis of isolates from breakthrough infections following vaccination with AZD1222/Covishield and BBV152/Covaxin. Variants of concern B.1.617.2 and B.1.1.7 responsible for cases surge in April-May 2021 in Delhi, were the predominant lineages among breakthrough infections.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662202 | PMC |
| http://dx.doi.org/10.1002/jmv.27461 | DOI Listing |
Publication Analysis
Top Keywords
breakthrough infections
16
variants concern
8
concern responsible
4
responsible sars-cov-2
4
sars-cov-2 vaccine
4
breakthrough
4
vaccine breakthrough
4
infections
4
infections india
4
india emerging
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!